Floatz logo

Probio-M9

Probio-M9

Seventh Medical Center of PLA General HospitalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Probio-M9 cohort.

Asset / SponsorPhaseRating
Tislelizumab
Seventh Medical Center of PLA General Hospital
Phase 2CCC

Same molecule, other indications

Probio-M9 is also rated in:

rectum adenocarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
TislelizumabDormant
CCC
Indicative ·
53 / 100
View asset →
RandomizedDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →